Page 297 - FINAL PROGRAMME 2017

P-654 Identi cation of high-risk carrier couples with limited versus expanded carrier screening panels
S. Rodriguez1, S. Yarnall2, N. Kumar2
1Recombine, Product, New York- N.Y., U.S.A. 2CooperGenomics, Medical Affairs, New York, U.S.A.
P-655 DNA methylation at imprinted genes varies with infertility diagnosis in infertile men
R. Ng1, S. Pitigalaarachchige1, A. Pradhan1, K. Poon1, V. Chow1, S. Ma1 1University of British Columbia, Vancouver- BC, Canada
P-656 Importance of the Aging Male Gamete on ART Outcome
P. Xie1, S. Cheung1, Z. Rosenwaks1, G. Palermo1
1Weill Cornell Medicine, The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, New York, U.S.A.
P-657 Is more better? A higher oocyte yield is independently associated with more day-3 euploid embryos
A. Kan1, L. Tilia2, E. Panlilio2, C. Venetis1,3
1IVFAustralia, South, Kogarah- NSW, Australia
2IVFAustralia, East, Maroubra- NSW, Australia
3University of New South Wales, UNSW Medicine, Sydney, Australia
P-658 Alterations in endocrine and paracrine regulation of oocyte maturation and folliculogenesis un- derlie the etiology of primary ovarian insuf ciency
K. Kalmbach1, D.E. Par tt1, T. Hu-Seliger1, C. Clementi1, A. Oromendia1, P. Yurttas Beim1 1Celmatix Inc, Research and Development, New York, U.S.A.
P-659 A multivariate genome-wide DNA methylation analysis of placental villi from assisted reproduc- tive technology and naturally conceived pregnancies
K. Louie1, E. Chan Wong1, S. Ma1
1University of British Columbia, Obstetrics and Gynaecology, Vancouver, Canada
P-660 Differences in aneuploidy survival to rst trimester of aneuploid embryos
P. Colls1, T. Escudero2, S. Munne2
1Reprogenetics, Livingston- New Jersey, U.S.A.
2Reprogenetics- A CooperSurgical Company, Research, Livingston- New Jersey, U.S.A.
P-661 Preimplantation genetic diagnosis (PGD) for multiple indications: patient outcomes
D. Goldberg-Strassler1, R. Prates2, M. Konstantinidis2, R. Cabey1, J. Gay3, A. Jordan1, E. Armenti1 1Reprogenetics, Genetic Counseling, Livingston, U.S.A.
2Reprogenetics, Molecular, Livingston, U.S.A.
3Reprogenetics, Genetic Counseling, Livginston, U.S.A.
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 297
POSTERS